Recent Analysts’ Ratings Changes for Corteva (CTVA)

Several analysts have recently updated their ratings and price targets for Corteva (NYSE: CTVA):

  • 11/16/2026 – Corteva had its price target lowered by KeyCorp from $17.00 to $14.00. They now have an “overweight” rating on the stock.
  • 11/14/2026 – Corteva was downgraded by Wall Street Zen from “hold” to “sell”.
  • 11/13/2026 – Corteva was downgraded by Oppenheimer from “outperform” to “market perform”.
  • 11/13/2026 – Corteva had its price target lowered by Citigroup from $13.65 to $10.30. They now have a “neutral” rating on the stock.
  • 11/13/2026 – Corteva had its price target lowered by JPMorgan Chase & Co. from $19.00 to $16.00. They now have an “overweight” rating on the stock.
  • 11/13/2026 – Corteva had its price target lowered by UBS Group from $15.00 to $10.00. They now have a “neutral” rating on the stock.
  • 11/13/2026 – Corteva had its price target lowered by Royal Bank Of Canada from $17.00 to $11.00. They now have an “outperform” rating on the stock.
  • 11/12/2026 – Corteva was given a new $16.00 price target by Mizuho.
  • 10/12/2026 – Corteva had its price target lowered by UBS Group to $15.00. They now have a “neutral” rating on the stock.
  • 10/8/2026 – Corteva had its “buy” rating reaffirmed by The Goldman Sachs Group. They now have a $20.00 price target on the stock.
  • 10/7/2026 – Corteva had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $17.00 price target on the stock.
  • 10/7/2026 – Corteva was upgraded by KeyCorp from “sector weight” to “overweight”. They now have a $17.00 price target on the stock.
  • 10/6/2026 – Corteva was downgraded by Zacks Research from “hold” to “strong sell”.
  • 10/6/2026 – Corteva was upgraded by JPMorgan Chase & Co. from “neutral” to “overweight”. They now have a $19.00 price target on the stock.
  • 10/5/2026 – Corteva was given a new $17.00 price target by New Street Research.
  • 10/5/2026 – Corteva was given a new $17.00 price target by Oppenheimer.
  • 10/2/2026 – Corteva was given a new $15.00 price target by BMO Capital Markets.
  • 10/2/2026 – Corteva had its “overweight” rating reaffirmed by Morgan Stanley. They now have a $18.00 price target on the stock.
  • 9/24/2026 – Corteva had its “outperform” rating reaffirmed by Oppenheimer. They now have a $95.00 price target on the stock.
  • 9/18/2026 – Corteva had its “buy” rating reaffirmed by Argus. They now have a $91.00 price target on the stock.

Corteva Stock Performance

Shares of Corteva stock opened at $9.02 on Tuesday. Corteva, Inc. has a 52 week low of $8.87 and a 52 week high of $90.97. The business’s fifty day simple moving average is $35.65 and its 200-day simple moving average is $69.25. The firm has a market cap of $6.02 billion, a PE ratio of 4.75, a price-to-earnings-growth ratio of 1.72 and a beta of 0.58. The company has a quick ratio of 1.10, a current ratio of 1.56 and a debt-to-equity ratio of 0.14.

Corteva Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be issued a $0.05 dividend. This is a decrease from Corteva’s previous quarterly dividend of $0.18. The ex-dividend date is Tuesday, December 1st. This represents a $0.20 annualized dividend and a yield of 2.2%. Corteva’s payout ratio is presently 37.89%.

Insider Buying and Selling

In related news, CEO Luther C. Iv Kissam bought 32,292 shares of the firm’s stock in a transaction on Friday, November 13th. The shares were bought at an average price of $9.30 per share, with a total value of $300,315.60. Following the completion of the transaction, the chief executive officer directly owned 185,379 shares of the company’s stock, valued at $1,724,024.70. This represents a 21.09% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.15% of the stock is owned by insiders.

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Read More

Receive News & Ratings for Corteva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva Inc and related companies with MarketBeat.com's FREE daily email newsletter.